Insider · CIK 0001698766
Carolyn R Bertozzi
Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.), OABI (OmniAb, Inc.). First filing -, latest -.
In brief
Carolyn R Bertozzi files SEC Form 4 as director at ALNY (ALNYLAM PHARMACEUTICALS, INC.), and also at OABI (OmniAb, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carolyn R Bertozzi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 113,308 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 0 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 20,000 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2026 |
| Nov 1, 2025 | OABI OmniAb, Inc. | MOption exercise Common Stock | +17,769 | - | - | 93,308 | Nov 3, 2025 |
| Nov 1, 2025 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -17,769 | $0.00 | $0 | 20,000 | Nov 3, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 75,539 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 17,769 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 37,769 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2025 |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock | +775 | $0.00 | $0 | 775 | May 12, 2025 |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,558 | $0.00 | $0 | 1,558 | May 12, 2025 |
| Nov 1, 2024 | OABI OmniAb, Inc. | MOption exercise Common Stock | +17,769 | - | - | 55,539 | Nov 1, 2024 |
| Nov 1, 2024 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -17,769 | $0.00 | $0 | 37,769 | Nov 1, 2024 |
| Jun 18, 2024 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 37,770 | Jun 21, 2024 |
| Jun 18, 2024 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 35,538 | Jun 21, 2024 |
| Jun 18, 2024 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 55,538 | Jun 21, 2024 |
| Jun 18, 2024 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 21, 2024 |
| May 16, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +5,228 | $0.00 | $0 | 5,228 | May 20, 2024 |
| Nov 1, 2023 | OABI OmniAb, Inc. | MOption exercise Common Stock | +17,770 | - | - | 17,770 | Nov 1, 2023 |
| Nov 1, 2023 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -17,770 | - | - | 55,538 | Nov 1, 2023 |
Questions about Carolyn R Bertozzi
Answered from the filings on this page, as of the latest one.
Is Carolyn R Bertozzi buying or selling?
Carolyn R Bertozzi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carolyn R Bertozzi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carolyn R Bertozzi has 0.
Where does Carolyn R Bertozzi file Form 4?
Carolyn R Bertozzi has filed Form 4 at ALNY (ALNYLAM PHARMACEUTICALS, INC.); OABI (OmniAb, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.